Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Don't be ridiculous. I already posted about one, except they have billions in cash.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174304081
Call For Doctors/Med Spa owners on this Board to Share Daxxify Sales Data
As you all know, I am a long time injector of Daxxify since Prevu Dec 2022. I launched conservatively to a small portion of my practice, and since that time, Daxxify has taken over 80% of my own NT business (not including my nurse injectors). I used to be Botox only. This is the biggest revenue shift that I have seen in my practice in 20 years.
I am also seeing gradual adoption of Daxxify from many of my nurse injectors the past 3 quarters and we did over 6 figures of Daxxify purchases (over 400 vials) in Q1 2024. The march $75 rebates did help to get us to buy more Daxxify and to entice clients to try Daxxify. This represents over 500% growth over the Daxxify vials I used in Q12023. Although I am still the largest single injector of Daxxify in my organization, my nurse injectors, as a group, exceeded my total vials injected in Q4 2023 and have continued to grow their percentage of Daxxify used within my company.
I am seeing a 54% Daxxify adoption rate within my practice (7 of 13 nurses who trialed it in Q2/Q3 2023 are now ramping up sales in a meaningful way = 10 or more vials a month of Daxxify purchases). 25% are ramping up at a slower rate and 25% tried it and kind of gave up and couldn't quite figure it out or didn't want to take the time and effort to. This implies that roughly 50% of experienced nurse injectors will take 6 to 9 months to get comfortable with their injection outcomes and sales pitch before blowing it out, these nurse injectors tend to be our more authoritative and expert injectors - the type of nurse injectors that clients trust implicitly with 10 or more years of experience. These nurses are the heavy lifters in the NT industry that typically do 40 to 70 vials of NT each month. They likely account for 50% of the US NT market. They are my heavy hitters and largest profit centers. Moreover, the transition to Daxxify is making our organization more profitable with higher client satisfaction rates.
Emmanow, Edcoolidge, Boraborak38, others: would you be able to share some of your Daxxify purchase data for the board to gain some color on traction of Daxxify within your practice?
RVNC is much worse than most recently. Actually, find me another name that has 350mm cash on hand, that is down close to 40 percent MTD.
It’s clearly not just inflation or interest rate.
Perhaps the better question to Ms. Dtox would be: Do you feel the pricing change last fall and the change in messaging early this year and injectors getting more experience with the product have helped to course correct Daxi and do you feel that the worse is behind the Daxxify commercial launch?
The Board of Directors meeting is May 1st so there will probably be a preliminary earnings announcement before their May 5th Q1 date.
Also AbbVie will announce Botox sales tomorrow morning!
RVNC has cash to get them through the end of 2025.
CD Daxi sales will start May 9th…there is already a backlog of orders!
China approve any day!
I am convinced AbbVie has a fund which is shorting RVNC.
There are dozens or hundreds of comparisons just like this. RIVN makes fine products but they're unprofitable and their pathway to profitability is uncertain—not something people want to own in this interest rate environment. I don't own that stock but I've been looking for an entry point as I expect them to survive and they could easily be worth 10x in 10 years—but Rivian is far more likely than Revance to go bankrupt given the capital intensive nature of their business.
Trading for cash in bank now. Best product on market but terrible execution. No IR department to pitch the business. Crazy how they offered at 6.25 and a month later price is 3.25. They need to support the stock and Foley is silent until Q1 call which is when? Hope we get a PR…
You seem to be very naive and unaware about the movement of interest rates and inflation or that the exact same thing happening to RVNC is happening to many other loss-making companies right now. Some of these companies will go bankrupt but many won't. Market irrationality always lasts longer than you think but it doesn't last forever.
For sure, I would have never thought this will drop to this low.
Unless some fraud going on, I see this stock worth double digits at least.
They just raised 100mm
And they have 250mm cash on hand end of last year
They have CD and potential oversea milestones coming
But the sentiment is worse than awful
I think it’s buying time and have acted accordingly
The number of posters here buying this as it was falling day after day over the last year is startling.
I thought the 3.50-3.70 range was going to be bottom.
May look like 2.25-40 range now.
Looking for a point to jump in.
Down another 9% today, at $3.25. This is now a question of survival in my opinion.
"Crazy good deal"
Hope you are right. At some point, we have to be concerned that RVNC might not be able to survive (if at all) without ruinous dilution. Not sure when we reach that point.
The actual fight hasn’t started yet and David already lost 90 percent of his blood
Sometimes being David is just not good enough against Goliath…..
Just picked up some more shares
It’s crazy how a failed initial launch can cost 90 percent drop of the share price
30k shares used to be 1mm plus
Now just 100k
Crazy good deal
Ms Dtox has been kindly and at personal risk trying to convey the situation from inside the company. For that, she's been accused of being an ABBV shill and 'full of it' among others. The stock is approaching $3. How about some gratitude and self reflection for a change?
There's nobody here who doesn't know what the trials showed.
Ptosis is CD?
Did you mean Dysphagia? Even one poster commented that injection technique and injection location in the muscle have changed over the years for CD injections.
Favor, since you work at Revance, can you please tell IT/web design to remove Jessica from IR website. I dialed the number and a payroll associate picked up…
I stand by what I said on 3/31/24 .”Like other Neurotoxins individual results vary. Improved skin texture/tone is the big differentiator for me personally.”
When I worked for Allergan we used Lippe Taylor for some but not all ads and marketing materials. We did create and produce our own marketing materials and photo shoots and social media campaigns about 30 percent of the time with success.
Sad, but true to all :(
Wonder what Erica’s budget is for 2024?
Enhanced and streamlined organizational structure:
— With the appointment of Erica Jordan as Chief Commercial Officer in the fourth quarter of 2023, the commercial organization was restructured to integrate and “streamline marketing, sales, commercial operations, professional part-nerships, strategy, data analytics and professional engagement functions”. The new structure is designed to support the company's strategic priorities by enhancing execution and performance while improving efficiencies.
Tried to ascertain 23’ Marketing/Advertising budget
( 10k), but as you know S,G & A* doesn’t get broken out by segment( doesn’t matter anyway, different model this year) last year: $297,732
($223,934–2022)
*SG&A expenses include most expenses related to running a business outside of
COGS. This includes salaries, rent, utilities, “advertising, marketing”, technology, and supplies not used in manufacturing.
Well, only couple weeks before Q1, so strap in , LFG !!! RVNC
Allergan has always used and uses external marketing agencies for all of their ads and marketing materials! Botox has a product manager and assistant product manager…2 people. The assistant is the fill in for the product manager when they move to another job!
Allergan is most likely seeing a slow erosion of Botox sales and they are using influencers to try and slow the erosion! Remember, it cost $5 full load cost to produce a vial of Botox and AbbVie sells it for $656 per vial. Botox is the cash cow of aesthetics so AbbVie wants that profit at ALL costs!
It’s kind of embarrassing that a year ago Daxxify was presented as an elite allocated product to create FOMO demand and now Daxxify is being pitched by a minor mom influencer, it’s like we don’t even know who or what we are. Vogue and Time Magazine and the pendulum swing to this? Consumers remember in the moment what is right in front of them and this is cringeworthy. 😕
Allergan has a great strategy here. They’ve got deep enough pockets to hire million dollar influencers (Kris Jenner promoting Botox gift cards) and they keep it more grassroots with casting calls. Revance is using C tier influencers because of budget constraints and the scripting/performance at that level can feel contrived. There is no marketing team left, so everything we see in near future will be outside agency generated with the agency fee taking the biggest bite out of marketing budget. There is no effective strategy in place at this time.
Marketing heating up in this space! Revance can’t let guard down, should be an interesting 2nd half, 2024
https://www.fiercepharma.com/marketing/abbvie-starts-open-casting-call-next-faces-botox-ads-doubling-down-pitch-everyday-users
I agree… perhaps so we remember it. 🙃
I think that ad is pretty annoying actually.
New DAXXIFY ad… ‘different’
https://www.instagram.com/reel/C6HC2SlO3xX/?igsh=c3I2YWN2dmlqeDEx
Oracle is moving its headquarters to Nashville. Hopefully, Foley will rent out the 18th floor with 2 bars and change his title to Commercial Real Estate Broker! This is a perfect time for Foley to resign as the RVNC CEO and move to a job which matches his skill set! Commercial Relator. 🥳🥳🥳
Daxxify is simply a better product in the market. Now with proper marketing strategy, sales should improve steadily.
The upside for here is just enormous even assuming very conservative market share
Don’t understand the continuous selling at all.
Daxxify dysphagia rates reported at 2.7 to 4.2%:
https://www.biospace.com/article/releases/u-s-fda-approves-first-therapeutic-indication-for-revance-s-daxxify-daxibotulinumtoxina-lanm-for-injection-for-the-treatment-of-cervical-dystonia/
Based on the ASPEN OLS study, symptoms continued to improve with successive DAXXIFY® treatments at doses up to 300U, while adverse events remained low.15-16 In particular, dysphagia rates (difficulty swallowing) remained low (2.7% for ASPEN-1 and 4.2% for ASPEN-OLS), further supporting DAXXIFY’s safety profile.15-16
Botox at 19%
https://www.botoxone.com/cervical-dystonia#:~:text=The%20most%20frequently%20reported%20adverse,%2C%20and%20headache%20(11%25).
The most frequently reported adverse reactions following injection of BOTOX for cervical dystonia include dysphagia (19%), upper respiratory infection (12%), neck pain (11%), and headache (11%).
I would expect that dysphagia rates with botox have dropped over time as technique has improved.
Revance also detailed Dysphagia rates in their presentation at the shareholder meeting last September and I believe that presentation is available on the Investor relation page of their website.
I can’t find the page where it shows a side by side comparison. That’s what you stated.
Still have not answered my question about your background.
Please review the clinical trials!
Why would Daxi have lower adverse events and Daxi injectors are being instructed to inject Daxi directly into the intended muscle! Daxi attaches very quickly to the neuron and does not spread! Versus Botox injection technique for the glabellar area which on the top side of the muscle knowing Botox will spread and cause adverse events.
Compare the 2 injection patterns published! Daxi just published their updated pattern versus the Botox pattern!
Now you know why Botox must be higher and why it takes up to 14 days to get the full effect! The Botox active ingredient floats around for several days and some finds the neurons..half of the active ingredient attaches to other tissues!
Is that your expert opinion as to why there is more adverse events or is that from clinical experience?
Yes, there is no head to head comparison published! One must compare the data from both PI’s.
Allergan will never tell patients that their active toxin floats around for up to 2 weeks in the patient’s tissues! Easy to understand why Daxi with the same active ingredient as Botox gives the patient double the duration of Botox. The Botox active ingredient attaches to many other areas and half never finds the neurons! The Botox active ingredient attached to areas not intended! That is why Botox has higher adverse events than Daxi in every clinical application!
The peptide in Daxi is the magic!
I did. I don’t see the head to head comparison. I understand the peptide portion of Daxi.
So are you just making a claim or a comparison?
It’s not as easy as you think.
Please review the PI for both Botox and Daxi for CD and compare!
There are many unhappy RVNC employees who have lost money with the SP. The SP will correct itself as RVNC sales grow and expenses are managed which will show profits! Foley is a hatchet man and reworked the RVNC business model with the new price of Daxi!
Daxi will be released early in May for CD. There are already orders for CD so shipments will happen immediately!
Cosmetic Daxi sales will continue to grow as the sales team works hard to teach accounts how to inject Daxi, make more profit and give patients an improved toxin experience.
Where does it state that in the PI?
Which section? Can you point me to that part of the clinical study?
Would love to read that. I’m kind of nerdy like that.
Followers
|
155
|
Posters
|
|
Posts (Today)
|
1
|
Posts (Total)
|
8621
|
Created
|
02/09/14
|
Type
|
Free
|
Moderators DewDiligence |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |